We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Michael R. Shanks
Michael R. Shanks
Products
PRODUCTS
Astellas Pharma Tech Co., Ltd.
Jacek Cieslak
,
Michael R. Shanks
, and
Maxwell Van Tassell
Price:
$117.00
View
Vetter Pharma-Fertigung GmbH & Co. KG
Ashley N. Queen
and
Michael R. Shanks
Price:
$117.00
View
Aspen SVP Pty Ltd.
Cheryl Clausen
and
Michael R. Shanks
Price:
$117.00
View
Aspen SVP Pty, Ltd.
Cheryl Clausen
and
Michael R. Shanks
Price:
$117.00
View
Samsung Biologics Corp., Ltd.
Virginia Carroll
,
Diane L. Raccasi
, and
Michael R. Shanks
Price:
$117.00
View
Sandoz GmbH
Laura Fontan
,
Deborah Schmiel
,
Michael R. Shanks
, and
Marjorie A. Shapiro
Price:
$117.00
View
Biogen (Denmark) Manufacturing ApS
Ralph M. Bernstein
,
Brian M. Janelsins
, and
Michael R. Shanks
Price:
$117.00
View
Amgen, Inc., Amgen Manufacturing, Ltd.
Christopher Downey
,
Michael R. Shanks
,
Jose Velez
, and
Timothy Wadkin
Price:
$117.00
View
GlaxoSmithKline
M Gutierrez Lugo
,
Richard A. Lyght
,
F Namuswe
,
Thuy Thanh Nguyen
,
Zhihao Peter Qiu
, and
Michael R. Shanks
Price:
$117.00
View
View All Products by Michael R. Shanks
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More